Two HIV drugs suspected of producing higher cardiovascular risk
FDA is looking at whether Ziagen and Videx is linked to more heart attacks.
A study has found that abacavir (Ziagen, GlaxoSmithKline) and didanosine (Videx, Bristol-Myers Squibb) are associated with an increased risk of heart attack. So the Food & Drug Administration has issued an early
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Recent Videos
Related Content
